We are thrilled to share that Digistain was hand selected by an expert panel of judges from EIT Health, AstraZeneca Spain, SERMAS and Hospital 12 de Octubre as the winners of the 2025 EIT Health Open Innovation Breast Cancer Challenge.
Recognised for the innovative potential of our technology to address inequalities in breast cancer care, this milestone paves the way for the rollout of the Digistain Test across Spain. As part of the prize, Hospital 12 de Octubre will be the first site where patients can benefit from rapid, accessible risk stratification, marking a significant step forward in improving breast cancer diagnostics.
